Clinical Trial Update: Antisecretory Factor Glioblastoma Phase 2 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating antisecretory factor for glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Antisecretory Factor (antisecretory factor)

Snippet

Sponsor: Peter Siesjö | Conditions: Glioblastoma | Phase 2, Phase 3 | Status: RECRUITING